Astro Pak launches decontamination services subsidiary
Astro Pak Corporation, a US precision cleaning company, has launched a subsidiary, SixLog, to provide on-site biological decontamination services using proprietary iHP (ionised hydrogen peroxide) technology to the life sciences, pharmaceutical and healthcare industries.
SixLog, headquartered in Santa Ana, California, performs decontamination services for equipment, rooms, entire buildings and modes of transport such as ambulances, trains and cruise ships.
The iHP bio decontamination technology was developed for military applications and this will be the first time that it will be used in commercial applications.
The company says technology can be used in open air and, once ionised, it acts like a gas as opposed to a vapour, providing excellent distribution properties and destroying micro-organisms even in hard-to-reach areas.
Steve Feinstein, formerly regional sales manager of a UK manufacturer of hydrogen peroxide vapour generators, has been appointed as SixLog's director of technology.
In addition to the company launch, SixLog has developed a website containing technical papers, presentations, and other downloads on biological decontamination and sterilisation.
You may also like
Manufacturing
ITT to acquire SPX FLOW in $4.8bn deal, expanding global leadership in engineered components and flow technologies
Read moreAcquisition strengthens ITT’s position in industrial, chemical, energy, health and nutrition markets, adding high-margin revenue, major aftermarket growth and $80m in expected synergies by year three
Trending Articles
You may also like
Manufacturing
ITT to acquire SPX FLOW in $4.8bn deal, expanding global leadership in engineered components and flow technologies
Acquisition strengthens ITT’s position in industrial, chemical, energy, health and nutrition markets, adding high-margin revenue, major aftermarket growth and $80m in expected synergies by year three
Finance
EIB and Angelini Ventures launch €150m fund to boost European biotech, medtech and digital health startups
The EIB and Angelini Ventures will co-invest €150 million to scale innovative European healthtech companies. The deal marks the EIB’s first partnership with a corporate venture capital fund in the healthcare sector
Finance
Fresh capital flows into neurodegeneration, cancer and vascular-access developers
A string of funding rounds and strategic financing deals across Europe’s life-sciences sector is breathing new life into companies working on high-need treatments — from neurodegeneration to cancer and dialysis access
Cleaning
BOLA product highlight flyer available now - Professional high-performance fluoroplastic labware
BOLA produces a range of sophisticated, professional laboratory products constructed from high-performance materials, developed and manufactured by in-house specialists with precision and attention to detail - available in the UK from Labtex